Literature DB >> 11193153

Alpha-secretase activity of the disintegrin metalloprotease ADAM 10. Influences of domain structure.

F Fahrenholz1, S Gilbert, E Kojro, S Lammich, R Postina.   

Abstract

Disintegrin metalloproteases from different organisms form the ADAM (a disintegrin and metalloprotease) family. All members display a common domain organization and possess four potential functions: proteolysis, cell adhesion, cell fusion, and cell signaling. Members of the ADAM family are responsible for the proteolytic cleavage of transmembrane proteins and release of their extracellular domain. The proteolytic process is referred to as ectodomain shedding, which is activated by phorbol esters and inhibited by hydroxamic acid-based inhibitors. We have shown that the disintegrin metalloprotease ADAM 10 has both constitutive and regulated alpha-secretase activity. Expression of a dominant negative mutant of ADAM 10 in HEK cells decreases the secretion of APPs alpha. In order to investigate the influence of distinct protein domains of ADAM 10 on alpha-secretase activity, several deletion mutants of ADAM 10 were constructed. Our findings demonstrate that the deletion of the disintegrin domain results in a mutant ADAM 10 with remaining alpha-secretase activity, whereas the deletion of the prodomain destroys the proteolytic activity of ADAM 10.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11193153     DOI: 10.1111/j.1749-6632.2000.tb06925.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  23 in total

1.  Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs.

Authors:  Claus-Werner Franzke; Kaisa Tasanen; Heike Schäcke; Zhongjun Zhou; Karl Tryggvason; Cornelia Mauch; Paola Zigrino; Susan Sunnarborg; David C Lee; Falk Fahrenholz; Leena Bruckner-Tuderman
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

Review 2.  An overview of APP processing enzymes and products.

Authors:  Vivian W Chow; Mark P Mattson; Philip C Wong; Marc Gleichmann
Journal:  Neuromolecular Med       Date:  2010-03       Impact factor: 3.843

3.  Sphingosylphosphorylcholine attenuated β-amyloid production by reducing BACE1 expression and catalysis in PC12 cells.

Authors:  Hyoseok Yi; Seong Jin Lee; Jiyeong Lee; Chang-Seon Myung; Woo-Kyu Park; Hee-Jong Lim; Ge Hyeong Lee; Jae Yang Kong; Heeyeong Cho
Journal:  Neurochem Res       Date:  2011-06-15       Impact factor: 3.996

Review 4.  ADAM-17: the enzyme that does it all.

Authors:  Monika Gooz
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-04       Impact factor: 8.250

5.  Regulation of ADAM10 by miR-140-5p and potential relevance for Alzheimer's disease.

Authors:  Rumana Akhter; Yvonne Shao; McKenzie Shaw; Shane Formica; Maria Khrestian; James B Leverenz; Lynn M Bekris
Journal:  Neurobiol Aging       Date:  2017-11-23       Impact factor: 4.673

6.  The Role of Shed PrPc in the Neuropathogenesis of HIV Infection.

Authors:  Bezawit W Megra; Eliseo A Eugenin; Joan W Berman
Journal:  J Immunol       Date:  2017-05-22       Impact factor: 5.422

Review 7.  Structural and mechanistic commonalities of amyloid-β and the prion protein.

Authors:  Bianca Da Costa Dias; Katarina Jovanovic; Danielle Gonsalves; Stefan F T Weiss
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

8.  ADAM10 expression and promoter haplotype in Alzheimer's disease.

Authors:  Lynn M Bekris; Franziska Lutz; Gail Li; Douglas R Galasko; Martin R Farlow; Joseph F Quinn; Jeffrey A Kaye; James B Leverenz; Debby W Tsuang; Thomas J Montine; Elaine R Peskind; Chang-En Yu
Journal:  Neurobiol Aging       Date:  2012-05-08       Impact factor: 4.673

9.  The role of zinc in Alzheimer's disease.

Authors:  Nicole T Watt; Isobel J Whitehouse; Nigel M Hooper
Journal:  Int J Alzheimers Dis       Date:  2010-12-20

10.  Induction of RAGE shedding by activation of G protein-coupled receptors.

Authors:  Verena V Metz; Elzbieta Kojro; Dorothea Rat; Rolf Postina
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.